Tsudome R, Suematsu Y, Tashiro K, et al. Anti-Oxidative Effect of Dapagliflozin, a Selective Sodium Glucose Transporter-2 Inhibitor, for Cardio-Renal Protection in Patients With Heart Failure With Reduced Ejection Fraction. Cardiol Res. 2025;16(6):489-498. doi:10.14740/cr2109